First-of-its-Kind Study Shows Visibility into Real-Time Spinal Cord Stimulation Utilization and Supports a New Standard of Long-Term Device Management

A new study published in Neuromodulation (1) demonstrates that automatic, daily remote monitoring of spinal cord stimulation (SCS) devices enables the first real-time visibility into post-implant ...
Business Wire

World's First and Only Upgradeable Spinal Cord Stimulation System Receives FDA Approval

Protégé upgradeable neurostimulator from St. Jude Medical is the world’s smallest, longest-lasting rechargeable device to treat chronic pain SCS system is designed to be non-invasively upgraded to ...
Business Wire

Spinal Modulation Axium™ Spinal Cord Stimulator System (SCS) Shows Promise in Managing Chronic Pain in Difficult Pain Conditions

LAS VEGAS, Nev.--(BUSINESS WIRE)--During the scientific sessions at the 16 th Annual NANS Conference, Dr. Liong Liem, Anesthesiologist at Sint Antonius Ziekenhuis in the Netherlands and member of the ...
Nasdaq

Boston Scientific's (BSX) Wavewriter Alpha SCS Gets FDA's Nod

Boston Scientific, Inc. BSX recently received FDA approval for an expanded indication of the WaveWriter Alpha Spinal Cord Stimulator (“SCS”) Systems. With this approval, the system will be available ...
News Medical

Spinal cord stimulation may help reduce chronic pain in people undergoing active cancer treatment

Researchers at Johns Hopkins University School of Medicine say they have evidence from a new study in rats that spinal cord stimulation (SCS) may be useful in reducing chronic pain in people ...
Seeking Alpha

Abbott wins FDA expanded indication for Eterna neuromodulation device

Abbott Laboratories (NYSE:ABT) announced Thursday that the FDA approved expanded MRI labeling for its pain relief device Eterna spinal cord stimulation (SCS) system, allowing its use in patients who ...
News Medical

Boston Scientific announces European launch of Precision Novi SCS System

Boston Scientific announces the European launch of the Precision Novi™ Spinal Cord Stimulator (SCS) System at the International Neuromodulation Society in Montreal, Canada. The 16-contact primary cell ...
Monthly Prescribing Reference

Abbott’s SCS System Cleared for Patients With Painful Diabetic Peripheral Neuropathy

It was originally approved in 2019 for the treatment of chronic pain. The Food and Drug Administration (FDA) has approved the Proclaim™ XR spinal cord stimulation (SCS) system for the treatment of ...
Nasdaq

Abbott (ABT) Expands in Canada With First Eterna SCS Use

Abbott ABT recently announced the first usage of its Eterna spinal cord stimulator (SCS) system in Canada. This marks a significant milestone in the company’s approach to chronic pain management. The ...